Kufril D Junior Syrup is a multi-symptom relief medication formulated for pediatric use, containing Phenylephrine, Chlorpheniramine Maleate, and Dextromethorphan Hydrobromide as active ingredients. Phenylephrine acts as a selective alpha-1 adrenergic receptor agonist, providing effective nasal decongestion by constricting dilated blood vessels in the nasal mucosa, thereby reducing swelling and facilitating easier breathing. Chlorpheniramine Maleate, a first-generation antihistamine, alleviates allergic symptoms such as runny nose, sneezing, and watery eyes by blocking H1 histamine receptors. Dextromethorphan Hydrobromide serves as a centrally acting antitussive agent, suppressing the cough reflex through its action on the medullary cough center in the brain, thus providing relief from dry, irritating coughs. Kufril D Junior Syrup is indicated for the symptomatic management of common cold, allergic rhinitis, and upper respiratory tract infections in children. It should be administered according to the prescribed dosage and duration to minimize potential adverse effects such as drowsiness, dry mouth, or gastrointestinal disturbances. Caution is advised in patients with hypertension, glaucoma, or thyroid disorders. Consultation with a healthcare professional is recommended prior to use to ensure safety and efficacy in the pediatric population.